MUFG Americas Holdings Corp boosted its position in UnitedHealth Group Incorporated (NYSE:UNH) by 13.3% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 51,563 shares of the healthcare conglomerate’s stock after buying an additional 6,070 shares during the period. MUFG Americas Holdings Corp’s holdings in UnitedHealth Group were worth $8,457,000 at the end of the most recent quarter.

A number of other hedge funds have also recently bought and sold shares of the company. Ellington Management Group LLC bought a new position in shares of UnitedHealth Group during the fourth quarter worth approximately $528,000. Highland Capital Management LP bought a new position in shares of UnitedHealth Group during the fourth quarter worth approximately $4,001,000. Retirement Systems of Alabama raised its position in shares of UnitedHealth Group by 2.5% in the first quarter. Retirement Systems of Alabama now owns 640,240 shares of the healthcare conglomerate’s stock worth $105,006,000 after buying an additional 15,403 shares during the period. Fiera Capital Corp raised its position in shares of UnitedHealth Group by 10.1% in the fourth quarter. Fiera Capital Corp now owns 630,755 shares of the healthcare conglomerate’s stock worth $100,945,000 after buying an additional 58,073 shares during the period. Finally, Polaris Capital Management LLC raised its position in shares of UnitedHealth Group by 23.5% in the fourth quarter. Polaris Capital Management LLC now owns 209,780 shares of the healthcare conglomerate’s stock worth $33,573,000 after buying an additional 39,884 shares during the period. 86.26% of the stock is currently owned by institutional investors.

UnitedHealth Group Incorporated (UNH) traded up 0.06% on Friday, hitting $194.88. 2,785,117 shares of the company’s stock were exchanged. UnitedHealth Group Incorporated has a 12-month low of $132.39 and a 12-month high of $196.04. The company has a market cap of $191.96 billion, a PE ratio of 23.41 and a beta of 0.64. The company’s 50-day moving average price is $186.80 and its 200-day moving average price is $173.05.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, July 18th. The healthcare conglomerate reported $2.46 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.38 by $0.08. UnitedHealth Group had a net margin of 4.32% and a return on equity of 21.52%. The business had revenue of $50.05 billion during the quarter, compared to analysts’ expectations of $49.97 billion. During the same quarter in the prior year, the business posted $1.96 EPS. The company’s revenue for the quarter was up 7.7% on a year-over-year basis. Analysts forecast that UnitedHealth Group Incorporated will post $9.87 earnings per share for the current year.

TRADEMARK VIOLATION WARNING: “MUFG Americas Holdings Corp Acquires 6,070 Shares of UnitedHealth Group Incorporated (NYSE:UNH)” was first reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this piece on another website, it was illegally copied and reposted in violation of United States & international copyright & trademark law. The original version of this piece can be accessed at https://www.thecerbatgem.com/2017/08/04/mufg-americas-holdings-corp-increases-position-in-unitedhealth-group-incorporated-nyseunh-updated-updated-updated.html.

A number of equities analysts have recently commented on UNH shares. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $200.00 target price on shares of UnitedHealth Group in a research report on Thursday, April 6th. Mizuho raised their target price on shares of UnitedHealth Group from $178.00 to $200.00 and gave the stock a “buy” rating in a research report on Tuesday, April 18th. Stifel Nicolaus reaffirmed a “buy” rating and set a $185.00 target price on shares of UnitedHealth Group in a research report on Wednesday, April 19th. Evercore ISI reaffirmed an “outperform” rating and set a $185.00 target price on shares of UnitedHealth Group in a research report on Wednesday, April 19th. Finally, Credit Suisse Group raised their target price on shares of UnitedHealth Group from $185.00 to $188.00 and gave the stock an “outperform” rating in a research report on Wednesday, April 19th. One analyst has rated the stock with a hold rating and twenty-four have issued a buy rating to the company. The stock currently has a consensus rating of “Buy” and an average target price of $200.24.

In related news, Director Gail R. Wilensky sold 5,540 shares of the stock in a transaction on Friday, June 2nd. The shares were sold at an average price of $178.74, for a total transaction of $990,219.60. Following the completion of the sale, the director now owns 60,516 shares in the company, valued at approximately $10,816,629.84. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director William C. Ballard, Jr. sold 5,000 shares of the stock in a transaction on Wednesday, June 7th. The stock was sold at an average price of $182.64, for a total transaction of $913,200.00. Following the sale, the director now owns 75,735 shares of the company’s stock, valued at approximately $13,832,240.40. The disclosure for this sale can be found here. 0.89% of the stock is owned by corporate insiders.

About UnitedHealth Group

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Stock Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related stocks with our FREE daily email newsletter.